These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9815525)
21. Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995. Pickar JH; Thorneycroft I; Whitehead M Am J Obstet Gynecol; 1998 May; 178(5):1087-99. PubMed ID: 9609589 [TBL] [Abstract][Full Text] [Related]
22. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort. Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161 [TBL] [Abstract][Full Text] [Related]
23. Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008. Fournier A; Dossus L; Mesrine S; Vilier A; Boutron-Ruault MC; Clavel-Chapelon F; Chabbert-Buffet N Am J Epidemiol; 2014 Sep; 180(5):508-17. PubMed ID: 25008104 [TBL] [Abstract][Full Text] [Related]
24. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
25. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
26. Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer. Doherty JA; Cushing-Haugen KL; Saltzman BS; Voigt LF; Hill DA; Beresford SA; Chen C; Weiss NS Am J Obstet Gynecol; 2007 Aug; 197(2):139.e1-7. PubMed ID: 17689625 [TBL] [Abstract][Full Text] [Related]
27. Endometrial cancer and hormone replacement therapy. Appropriate use of progestins to oppose endogenous and exogenous estrogen. Sulak PJ Endocrinol Metab Clin North Am; 1997 Jun; 26(2):399-412. PubMed ID: 9193892 [TBL] [Abstract][Full Text] [Related]
31. Hormone therapy to prevent disease and prolong life in postmenopausal women. Grady D; Rubin SM; Petitti DB; Fox CS; Black D; Ettinger B; Ernster VL; Cummings SR Ann Intern Med; 1992 Dec; 117(12):1016-37. PubMed ID: 1443971 [TBL] [Abstract][Full Text] [Related]
32. A practical guide to prescribing estrogen replacement therapy. Corson SL Int J Fertil Menopausal Stud; 1995; 40(5):229-47. PubMed ID: 8556028 [TBL] [Abstract][Full Text] [Related]
33. Sex steroids and breast cancer prevention. Spicer DV; Pike MC J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456 [TBL] [Abstract][Full Text] [Related]
34. [Estrogens, progestins and cancer of the endometrium]. Laffargue F; Daures JP Rev Prat; 1993 Dec; 43(20):2603-9. PubMed ID: 8146558 [TBL] [Abstract][Full Text] [Related]
37. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women. Josse RG CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542 [TBL] [Abstract][Full Text] [Related]
38. [Estrogens and progestins in hormone replacement therapy in menopause]. La Vecchia C Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854 [TBL] [Abstract][Full Text] [Related]
40. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer]. Magnusson C; Weiderpass E Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]